Publication | Closed Access

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

Breast OncologyEarly Breast CancerMedicinePharmacologyBreast CancerPharmacotherapyPrimary ChemotherapyAnti-cancer AgentCancer TreatmentOncologyCancer ChemotherapyProlonged Infusion